Title : Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer.

Pub. Date : 2000 Nov

PMID : 11096240






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer. Dextrans epidermal growth factor Homo sapiens
2 The aim of this study was to determine if intravesically administered EGF-dextran conjungate selectively accumulated in the tumor tissue and to correlate the uptake to tumor characteristics. Dextrans epidermal growth factor Homo sapiens
3 RESULTS: Five patients received EGF-dextran-(99m)Tc, three received dextran-(99m)Tc and one received only (99m)Tc. Dextrans epidermal growth factor Homo sapiens
4 CONCLUSION: The results are encouraging and further studies are warranted to investigate if EGF-dextran could be effective as intravesical therapy, either conjugated with cystostatic drugs or labeled with suitable radionuclides. Dextrans epidermal growth factor Homo sapiens